BIOMAT Database Logo BIOMAT Database Logo

[Plasma thromboxane B2 and 6-keto-prostaglandin F1-alpha concentrations in patients with essential and renovascular hypertension]. 1986

L S Gong, and X Y Shen, and H Y Ding

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013929 Thromboxane B2 A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin). B2, Thromboxane
D015121 6-Ketoprostaglandin F1 alpha The physiologically active and stable hydrolysis product of EPOPROSTENOL. Found in nearly all mammalian tissue. 6-Keto-PGF1 alpha,6-Oxo-PGF1 alpha,6-Oxoprostaglandin F1 alpha,6 Ketoprostaglandin F1 alpha,6 Keto PGF1 alpha,6 Oxo PGF1 alpha,6 Oxoprostaglandin F1 alpha,F1 alpha, 6-Ketoprostaglandin,F1 alpha, 6-Oxoprostaglandin,alpha, 6-Keto-PGF1,alpha, 6-Ketoprostaglandin F1,alpha, 6-Oxo-PGF1,alpha, 6-Oxoprostaglandin F1

Related Publications

L S Gong, and X Y Shen, and H Y Ding
Plasma concentrations of 6-keto-prostaglandin F1 alpha, thromboxane B2 and platelet aggregation in patients with essential hypertension.
November 1984, Japanese heart journal,
L S Gong, and X Y Shen, and H Y Ding
Plasma 6-keto prostaglandin F1 alpha and thromboxane B2 in sick preterm neonates.
May 1985, Prostaglandins, leukotrienes, and medicine,
L S Gong, and X Y Shen, and H Y Ding
[Changes in plasma thromboxane B2 and 6-keto-prostaglandin F1 alpha in bronchial asthma].
August 1990, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
L S Gong, and X Y Shen, and H Y Ding
[Plasma 6-keto-prostaglandin F1 alpha and thromboxane B2 levels in normal pregnancy and pregnancy-induced hypertension].
January 1988, Zhonghua fu chan ke za zhi,
L S Gong, and X Y Shen, and H Y Ding
[Evaluation of plasma 6-keto-prostaglandin F1 alpha and thromboxane B2 in diabetic neuropathy].
January 1987, Nihon Naibunpi Gakkai zasshi,
L S Gong, and X Y Shen, and H Y Ding
Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion.
January 1983, Advances in prostaglandin, thromboxane, and leukotriene research,
L S Gong, and X Y Shen, and H Y Ding
Relationship between thromboxane B2 and 6-keto-prostaglandin F1 alpha in sepsis.
March 1994, Research communications in chemical pathology and pharmacology,
L S Gong, and X Y Shen, and H Y Ding
Immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in neonatal hyperbilirubinemia.
January 1985, Prostaglandins, leukotrienes, and medicine,
L S Gong, and X Y Shen, and H Y Ding
[Thromboxane B2 and prostaglandin 6-keto-F1 alpha in the subretinal fluid].
July 1987, Klinika oczna,
L S Gong, and X Y Shen, and H Y Ding
Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1 alpha in endometriosis.
June 1981, American journal of obstetrics and gynecology,
Copied contents to your clipboard!